Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience

Journal of Heart and Lung Transplantation

Volumn 29, Issue 12, 2010, Pages 1395-1404

  De Soyza, Anthony ^a   Meachery, Gerard ^b   Hester, Katy L M ^b   Nicholson, Audrey ^b   Parry, Gareth ^b   Tocewicz, Krzysztof ^b   Pillay, Thasee ^b   Clark, Stephen ^b   Lordan, James L ^b   Schueler, Stephan ^b   Fisher, Andrew J ^a,b   Dark, John H ^b   Gould, F Kate ^b   Corris, Paul A ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Burkholderia cepacia complex; cystic fibrosis; genomovar; lung transplantation; survival

Indexed keywords

AZATHIOPRINE; AZTREONAM; CHLORAMPHENICOL; CLINDAMYCIN; CYCLOSPORIN; DOXYCYCLINE; FLUCLOXACILLIN; FOSFOMYCIN; GENTAMICIN; MEROPENEM; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TAUROLIDINE; TAZOBACTAM; TEMOCILLIN; THYMOCYTE ANTIBODY; TOBRAMYCIN;

ARTICLE; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CEPACIA INFECTION; CONTINUOUS INFUSION; CYSTIC FIBROSIS; HIGH RISK POPULATION; LUNG TRANSPLANTATION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SURVIVAL RATE;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CAUSE OF DEATH; COHORT STUDIES; CYSTIC FIBROSIS; FOLLOW-UP STUDIES; HUMANS; LUNG TRANSPLANTATION; RETROSPECTIVE STUDIES; SEPSIS; SPECIES SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78649327706     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.06.007     Document Type: Article

References (40)

1. F. Harrison Microbial ecology of the cystic fibrosis lung Microbiology 153 2007 917 923
2. E. Mahenthiralingam, and P. Vandamme Taxonomy and pathogenesis of the Burkholderia cepacia complex Chronic Respir Dis 2 2005 209 217 (Pubitemid 41527263)
3. J.R. Govan, A.R. Brown, and A.M. Jones Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection Future Microbiol 2 2007 153 164
4. J.J. Lipuma Update on the Burkholderia cepacia complex Curr Opin Pulmon Med 11 2005 528 533
5. T.G. Liou, M.S. Woo, and B.C. Cahill Lung transplantation for cystic fibrosis Curr Opin Pulmon Med 12 2006 459 463
6. J.D. Hosenpud, L.E. Bennett, and B.M. Keck Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease Lancet 351 1998 24 27
7. S. Husain, and N. Singh Burkholderia cepacia infection and lung transplantation Sem Respir Infect 17 2002 284 290
8. M. de Perrot, C. Chaparro, and K. McRae Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival J Thorac Cardiovasc Surg 127 2004 1493 1501
9. C. Chaparro, J. Maurer, and C. Gutierrez Infection with Burkholderia cepacia in cystic fibrosis; outcome following lung transplantation Am J Respir Crit Care Med 163 2001 43 48
10. W.I. Mariencheck Jr, S.M. Palmer, and V.F. Tapson Survival following lung transplantation of cystic fibrosis patients colonized with Burkholderia cepacia Am J Respir Crit Care Med 161 2000 720
11. J.B. Orens, M. Estenne, and S. Arcasoy International guidelines for the selection of lung transplant candidates: 2006 updatea consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 25 2006 745 755
12. E. Mahenthiralingam, B. Bischof, and S.K. Byrne DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III J Clin Microbiol 38 2000 3165 3173
13. A. De Soyza, A. McDowell, and L. Archer Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis Lancet 358 2001 1780 1781 (Pubitemid 33153006)
14. R.M. Aris, J.C. Routh, and J.J. LiPuma Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex Survival linked to genomovar type Am J Respir Crit Care Med 164 2001 2102 2106
15. A. De Soyza, K. Morris, and A. McDowell Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation Thorax 59 2004 526 528
16. P. Botha, L. Archer, and R.L. Anderson Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome Transplantation 85 2008 771 774
17. V. Boussaud, R. Guillemain, and D. Grenet Clinical outcome following lung transplantation in cystic fibrosis patients colonized with Burkholderia cepacia complex: results from two French centers Thorax 63 2008 732 737
18. J.D. Perry, G. Riley, and S. Johnston Activity of disinfectants against Gram-negative bacilli isolated from patients undergoing lung transplantation for cystic fibrosis J Heart Lung Transplant 21 2002 1230 1231
19. M.J. Ledson, M.J. Gallagher, and M. Robinson A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia J Aerosol Med 15 2002 51 57
20. J.M. Andrews BSAC standardized disc susceptibility testing method (version 5) J Antimicrob Chemother 58 2006 511 529
21. S.D. Aaron, W. Ferris, and D.A. Henry Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia Am J Respir Crit Care Med 161 2000 1206 1212 (Pubitemid 30243831)
22. B.J. Lang, S.D. Aaron, and S.W. Ferris Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa Am J Respir Crit Care Med 162 2000 2241 2245
23. M. Estenne, J. Maurer, and A. Boehler Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 2001 297 310
24. G. Meachery, A. De Soyza, and A. Nicholson Outcomes of lung transplantation for cystic fibrosis in a large UK cohort Thorax 63 2008 725 731
25. J.R. Govan, P.H. Brown, and J. Maddison Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis Lancet 342 1993 15 19
26. J.R. Govan Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex J R Soc Med 38 2000 40 45
27. E. Mahenthiralingam, P. Vandamme, and M.E. Campbell Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans Clin Infect Dis 33 2001 1469 1475
28. J.S. Chen, K.A. Witzmann, and T. Spilker Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis J Pediatr 139 2001 643 649
29. A. Isles, I. Maclusky, and M. Corey Pseudomonas cepacia infection in cystic fibrosis: an emerging problem J Pediatr 104 1984 206 210
30. T.L. Pitt, M.E. Kaufmann, and P.S. Patel Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland J Med Microbiol 44 1996 203 210
31. L. Blackburn, K. Brownlee, and S. Conway 'Cepacia syndrome' with Burkholderia multivorans, 9 years after initial colonization J Cystic Fibros 3 2004 133 134
32. A.K. Webb, and J. Egan Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation? Thorax 52 1997 671 673
33. J.J. Egan, K. McNeil, and B. Bookless Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia Lancet 344 1994 552 553
34. S. Murray, J. Charbeneau, and B.C. Marshall Impact of Burkholderia infection on lung transplantation in cystic fibrosis Am J Respir Crit Care Med 178 2008 363 371
35. B.D. Alexander, E.W. Petzold, and L.B. Reller Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex Am J Transplant 8 2008 1025 1030
36. S.D. Aaron Antibiotic sensitivity testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms Paediatr Respir Rev 8 2007 256 261
37. S.D. Aaron, K.L. Vandemheen, and W. Ferris Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial Lancet 366 2005 463 471
38. V. Waters, and F. Ratjen Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis Cochrane Database Syst Rev 2008 CD006961
39. J.E. Foweraker, C.R. Laughton, and D.F. Brown Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis Antimicrob Agents Chemother 53 2009 4809 4815
40. J.E. Foweraker, C.R. Laughton, and D.F. Brown Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbations of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing J Antimicrob Chemother 55 2005 921 927